Aqua­nitro(α,β,γ,δ‐tetra­phenyl­porphy­rinato)­cobalt(III) N,N‐di­methyl­form­amide disolvate

In the title compound, [Co(tpp)(NO₂)(H₂O)]·2dmf or [Co(C₄₄H₂₈N₄)(NO₂)(H₂O)]·2C₃H₇NO, a distorted octahedral Co^III complex shows an orientational disorder such that the positions of the nitro and aqua ligands are exchanged. As a result, the averaged structure has an inversion centre at the Co atom. The di­methyl­form­amide mol­ecule also has a positional disorder.     

Bis­[1,3‐bis­(tri­methyl­silyl)­allyl]­cobalt(II), a stable electron‐deficient allyl complex

The title compound, bis­[(1,2,3‐η)‐(2E)‐1,3‐bis­(tri­methyl­silyl)­prop‐2‐enyl]­cobalt(II), [Co(C₉H₂₁Si₂)₂], is a homoleptic allyl complex with η³‐bound ligands. The Co—C distances range from 1.996 (3) to 2.096 (3) Å and the allyl ligands adopt staggered, nearly parallel, arrangements around the Co atom. The tri­methyl­silyl groups are in syn–anti conformations; the steric shielding they provide to the metal is probably responsible for the thermal stability of the compound.     

Berberine formate–succinic acid (1/1)

The title compound [systematic name: 9,10‐di­methoxy‐2,3‐methyl­ene­dioxy‐5,6‐di­hydro­dibenzo­[a,g]­quinolizinium form­ate–succinic acid (1/1)], C₂₀H₁₈NO₄⁺·CHO₂⁻·C₄H₆O₄, con­tains centrosymmetric pairs of almost planar berberine cations, and hydrogen‐bonded (C₄H₆O₄⋯HCOO⁻)₂ rings of succinic acid with formate anions, bonded by O—H⋯O hydrogen bonds with O⋯O distances of 2.4886 (15) and 2.5652 (16) Å. Pairs of cations and mol­ecules of succinic acid are connected by non‐conventional weak C—H⋯O hydrogen bonds, with C⋯O distances of 3.082 (2) and 3.178 (2) Å.     

Hydrogen bonding in two salts of 3‐methylthio‐4‐(propargylthio)quinoline

In 3‐methyl­thio‐4‐(propargyl­thio)­quinolinium chloride monohydrate, C₁₃H₁₂NS₂⁺·Cl^?·H₂O, and 3‐methyl­thio‐4‐(propargyl­thio)­quinolinium tri­chloro­acetate, C₁₃H₁₂­NS₂⁺·­C₂Cl₃O₂^?, the terminal alkyne group forms C[triple‐bond]C—H?O hydrogen bonds of favourable geometry. The conformation of the flexible propargyl­thio group is different in the two structures.     

Diiso­propyl­phosphitocobalamin–acetone–water (1/3.48/7.56)

The di­iso­propyl­phosphite ligand in the title diiso­propyl­phosphitocobalamin compound, [Co(C₆₈H₁₀₂N₁₃O₁₇P₂)]·3.48C₃H₆O·7.56H₂O, coordinates to the Co^III atom via its P atom. The crystal structure is isomorphous with that of other cobalamins that adopt packing type II [Gruber, Jogl, Klintschar & Kratky (1998). Vitamin B₁₂ and B₁₂ Proteins, edited by Kräutler, Arigoni & Golding, pp. 335–347. New York: Wiley–VCH], with a Co—P bond length [2.227 (1) Å] similar to that found in other phosphitocobalamins. The structural trans influence in cobalamins is discussed.     

Thia­mine tetra­phenyl­borate monohydrate: a two‐dimensional hydrogen‐bonded network with (4,4)‐topology

The title compound, 3‐[(4‐amino‐2‐methyl­pyrimidin‐5‐yl)­meth­yl]‐5‐(2‐hydroxy­eth­yl)‐4‐methyl­thia­zolium tetra­phenyl­borate monohydrate, C₁₂H₁₇N₄OS⁺·C₂₄H₂₀B⁻·H₂O, is a salt in which the thiamine cations are linked by hydrogen bonds into a two‐dimensional network having (4,4)‐topology. The stacked sheets form channels, which are occupied by the anions; the cations and anions are linked by C—H⋯π(arene) hydrogen bonds.     

A structural hierarchy in the hydrogen‐bonded adduct N,N′‐di­methyl­piperazine–tartaric acid–water (1/2/2): an N‐component N‐dimensional structure (N = 3) with substructures having N = 1 and 2

In the hydrated adduct N,N′‐di­methyl­piperazine‐1,4‐diium bis(3‐carboxy‐2,3‐di­hydroxy­propanoate) dihydrate, [MeNH(CH₂CH₂)₂NHMe]²⁺·2(C₄H₅O₆)^?·2H₂O or C₆H₁₆N₂²⁺·2C₄H₅O₆^?·2H₂O, formed between racemic tartaric acid and N,N′‐di­methyl­piperazine (triclinic P, Z′ = 0.5), the cations lie across centres of inversion. The anions alone form chains, and anions and water mol­ecules together form sheets; the sheets are linked by the cations to form a pillared‐layer framework. The supramolecular architecture thus takes the form of a family of N‐dimensional N‐component structures having N = 1, 2 or 3.     

Hydrogen bonding and π–π stacking in methyl­aminium 4′,7‐dihydroxy­isoflavone‐3′‐sulfonate dihydrate and hexa­aqua­iron(II) bis­(4′,7‐diethoxy­isoflavone‐3′‐sulfonate) tetra­hydrate

In methyl­aminium 4′,7‐dihydroxy­isoflavone‐3′‐sulfonate dihydrate, CH₆N⁺·C₁₅H₉O₇S⁻·2H₂O, 11 hydrogen bonds exist between the methyl­aminium cations, the iso­flavone‐3′‐sulfonate anions and the solvent water mol­ecules. In hexa­aqua­iron(II) bis­(4′,7‐diethoxy­isoflavone‐3′‐sulfonate) tetra­hydrate, [Fe(H₂O)₆](C₁₉H₁₇O₇S)₂·4H₂O, 12 hydrogen bonds exist between the centrosymmetric [Fe(H₂O)₆]²⁺ cation, the isoflavone‐3′‐sulfonate anions and the solvent water mol­ecules. Additional π–π stacking inter­actions generate three‐dimensional supramolecular structures in both compounds.     

cyclo(‐Cha–Oxz–d‐Val–Thz–Ile–Oxz–d‐Val–Thz‐) N,N‐di­methyl­acetamide dihydrate: a square form of cyclo­hexyl­alanine‐incorporated ascidiacycl­amide having the strongest cytotoxicity

The title compound, 1‐cyclo­hexyl­methyl‐1‐de(1‐methyl­propyl)­asci­dia­cycl­amide N,N‐di­methyl­acet­amide di­hy­drate, C₃₉H₅₆N₈O₆S₂·C₄H₉NO·2H₂O, a cyclo­hexyl­alanine‐incorporated ascidiacycl­amide analogue ([Cha]ASC), shows a square form similar to natural ASC. On the other hand, CD (circular dichroism) spectra showed [Cha]ASC to have a folded structure in solution, making it the second known analogue to show a discrepancy between its crystal and solution structures. Moreover, the cytotoxicity of [Cha]ASC (ED₅₀ = 5.6 µg ml⁻¹) was approximately two times stronger than that of natural ASC or a related phenyl­alanine‐incorporated analogue, viz. cyclo(‐Phe–Oxz–d ‐Val–Thz–Ile–Oxz–d ‐Val–Thz‐) ([Phe]ASC), and was confirmed to be associated with the square form. However, [Phe]ASC was previously shown to be folded in the crystal structure, which suggests that the difference between the aromatic and aliphatic rings affects the molecular folding of the ASC mol­ecule.     

A dimeric constrained‐geometry titanium complex linked by double Ti–CH2–Al–CH2 heterocycles

In the structure of bis({N‐[di­methyl(1η⁵‐2,3,4,6‐tetra­methyl­in­den­yl)­silyl]­cyclo­hexyl­amido‐1κN}(methyl‐3κC)‐di‐μ₃‐methyl­ene‐1:2:3κ³C;1:3:3′κ³C‐tris(pentafluorophenyl‐2κC)titanium) benzene disolvate, [Me₂Si(η⁵‐2,3,4,6‐Me₄C₉H₂)(C₆H₁₁N)]Ti[(μ₃‐CH₂)Al(C₆F₅)₃][AlMe(μ₃‐CH₂)]₂ or [Ti₂(C₂₁H₇AlF₁₅)₂(C₂₁H₃₁NSi)₂]·2C₆D₆, the dimer is located on an inversion center, and the two Ti centers are linked by double Ti(μ₃‐CH₂)Al(C₆F₅)₃AlMe(μ₃‐CH₂) heterocycles. The electron‐deficient Ti centers are further stabilized by two α‐agostic interactions between Ti and one H atom of each bridging methyl­ene group.     

Tetrakis(3,5‐di­methyl­pyridine)­dihydrido­silicon dibromide bis(aceto­nitrile) solvate and 3,5‐dimethylpyridinium bromide

In the course of an attempt to synthesize tetrakis(3,5‐di­methyl­pyridine)­dihydridosilicon dibromide, crystals of its aceto­nitrile disolvate, C₂₈H₃₈N₄Si²⁺·2Br^?·2C₂H₃N, (I), and of 3,5‐di­methyl­pyridinium bromide, C₇H₁₀N⁺·Br^?, (II), were obtained in the same reaction flask. They have both been structurally characterized.     

[Hydroxy(aryl)methylene]diphos­phonic acids,a class of drugs in bone pathology treatments,crystallize as head‐to‐head dimers

Two [hydroxy­(aryl)­methyl­ene]­di­phospho­nic acids have been crystallized as dimers. The first compound, [hydroxy­(phenyl)­methyl­ene]­di­phospho­nic acid monohydrate, C₇H₁₀O₇P₂·H₂O, crystallizes in the non‐centrosymmetric space group P2₁, with the two enantiomers related by a non‐crystallographic centre of inversion, while the second compound, [hydroxy(4‐nitro­phenyl)­methyl­ene]­di­phospho­nic acid tetra­hydro­furan disolvate, C₇H₉NO₉P₂·2C₄H₈O, crystallizes in the centrosymmetric space group P2₁/c and uses the centre of symmetry to form the same dimer.     

{2,6‐Bis­[(di­methyl­amino)­methyl]pyridine‐κ3N}(2,2‐methyl­enediphenolato‐κ2O,O′)­dioxouranium(VI) acetone solvate

In the title compound, [UO₂(C₁₃H₁₀O₂)(C₁₁H₁₉N₃)]·C₃H₆O, the U atom is in a pentagonal–bipyramidal environment, with the three N atoms of the 2,6‐bis­[(di­methyl­amino)­methyl]­pyridine ligand and the two O atoms of the dianionic 2,2′‐methyl­ene­diphenolate ligand in the equatorial plane. The geometry is compared with that of previously reported 1:2 uranyl–diphenoxide complexes.     

η5‐(3)‐1‐Methyl‐1,2‐dicarbollyl‐η5‐2′,5′‐dimethylpyrrolylcobalt(III)

In the title compound, (η⁵‐2,5‐di­methyl­pyrrolyl)[(7,8,9,10,11‐η)‐7‐methyl‐7,8‐dicarba‐nido‐undecaborato]­cobalt(III), [3‐Co{η⁵‐[2,5‐(CH₃)₂‐NC₄H₂]}‐1‐CH₃‐1,2‐C₂B₉H₁₀] or [Co(C₃H₁₃B₉)(C₆H₈N)], the Co^III atom is sandwiched between the pentagonal faces of the pyrrolyl and dicarbollide ligands, resulting in a neutral mol­ecule. The C—C distance in the dicarbollide cage is 1.649 (3) Å.     

7‐Carboxyl­ato‐8‐hydroxy‐2‐methyl­quinolinium monohydrate and 7‐carboxy‐8‐hydroxy‐2‐methyl­quinolinium chloride monohydrate at 100 K

Both 7‐carboxyl­ato‐8‐hydroxy‐2‐methyl­quinolinium monohydrate, C₁₁H₉NO₃·H₂O, (I), and 7‐carboxy‐8‐hydroxy‐2‐methyl­quinolinium chloride monohydrate, C₁₁H₁₀NO₃⁺·Cl⁻·H₂O, (II), crystallize in the centrosymmetric P space group. Both compounds display an intramolecular O—H⋯O hydrogen bond involving the hydroxy group; this hydrogen bond is stronger in (I) due to its zwitterionic character [O⋯O = 2.4449 (11) Å in (I) and 2.5881 (12) Å in (II)]. In both crystal structures, the HN⁺ group participates in the stabilization of the structure via intermolecular hydrogen bonds with water mol­ecules [N⋯O = 2.7450 (12) Å in (I) and 2.8025 (14) Å in (II)]. In compound (II), a hydrogen‐bond network connects the Cl⁻ anion to the carboxylic acid group [Cl⋯O = 2.9641 (11) Å] and to two water mol­ecules [Cl⋯O = 3.1485 (10) and 3.2744 (10) Å].     

Hydrogen bonding in N,N,N′,N′‐tetra­methyl­ethyl­ene­di­ammonium bis­(benzene­selenol­ate)

The crystal structure of the title compound, [Me₂NHC₂H₄NHMe₂][SePh]₂ or C₆H₁₈N₂²⁺·2C₆H₅Se^?, reveals hydrogen bonding between the benzene­seleno­late anions and the tetra­methyl­ethyl­ene­di­ammonium cations. The asymmetric unit contains one formula unit of the title compound. The two Se?H distances are 2.22 (4) and 2.34 (4) Å.     

A donor–acceptor compound composed of a di­nuclear zinc(II) complex of a Robson macro­cycle with 8‐methyl­quino­line

A donor–acceptor compound, di­aqua‐1κO,2κO‐[μ‐11,23‐dimethyl‐3,7,15,19‐tetra­aza­tri­cyclo­[19.3.1.1^9,13]hexacosa‐1(25),2,7,9,11,13(26),14,19,21,23‐decaene‐25,­26‐diolato‐1κ⁴N³,N⁷,O²⁵,O²⁶:­2κ⁴N¹⁵,N¹⁹,O²⁵,O²⁶]­dizinc(II) diperchlorate bis(8‐methyl­quinoline) ethanol disolvate, [Zn₂(C₂₄H₂₆N₄O₂)(H₂O)₂](ClO₄)₂·2C₁₀H₉N·2C₂H₆O, obtained by the reaction of a dinuclear zinc(II) complex of a Robson macrocycle (acceptor) and 8‐methyl­quinoline (donor), lies about an inversion centre and the coordination about the unique Zn atom is a distorted square pyramid. The fifth coordination site is occupied by the water mol­ecule, Zn—O = 2.016 (2) Å, and the average macrocyclic Zn—O and Zn—N distances are 2.059 (6) and 2.059 (3) Å, respectively.     

(μ‐2,6‐Bis{[(2‐hydroxy­phenyl)­(2‐pyri­dyl­methyl)­amino]­methyl}‐4‐methyl­phenolato)­bis­[di­aqua­nickel(II)] ace­tate dimethyl­formamide 0.75‐hy­drate

The binuclear cation of the title compound, [Ni₂(C₃₃H₂₉­N₄O₃)(H₂O)₄]C₂H₃O₂·C₃H₇NO·0.75H₂O, was synthesized as a model for the active site of urease. Two tridentate halves of the symmetrical 2,6‐bis{[(2‐hydroxy­phenyl)(2‐pyridyl­methyl)­amino]­methyl}‐4‐methyl­phenolate (BPPMP^3?) ligand are arranged in a meridional fashion around the two Ni^II ions, with the phenoxo O atom bridging the Ni^II ions. The cation has an approximate twofold rotation axis running through the C—O bond of the bridging phenolate group. Four water mol­ecules complete the octahedral environment of each Ni^II ion.     

l‐Valyl‐l‐serine trihydrate

The valine side chains in the crystal structure of the title compound [systematic name: 2‐(2‐ammonio‐3‐methyl­butan­amido)‐3‐hydroxy­propano­ate tri­hydrate], C₈H₁₆N₂O₄·3H₂O, stack along an a axis of 4.77 Å to form hydro­phobic columns surrounded by remarkable water/hydroxyl shells. The peptide main chains are connected by hydrogen bonds in two‐dimensional layers. The peptide mol­ecules in each layer are related only by translation, and generate a very rare pattern. This is rendered possible through the formation of the shortest C^α—H·O(carboxyl­ate) inter­action ever recorded.     

The nitrate dihydrate of an aqua­dicopper(II) complex cation with guanidino­acetic acid and a novel trianionic disubstituted guanidine as ligands at 120 K

The structure of the title compound, aqua­[μ‐(N¹‐carboxylato­methyl­guanidino)­oxidoacetato](μ‐guanidino­acetic acid)­di­copper(II) nitrate dihydrate, [Cu₂(C₅H₆N₃O₅)(C₃H₇N₃O₂)(H₂O)]NO₃·2H₂O, contains two enantiomers of the di­copper(II) complex cation that comprise water, neutral zwitterionic guanidino­acetic acid and the trianion of (N¹‐carboxy­methyl­guanidino)­hydroxy­acetic acid as ligands. Extensive hydrogen bonding creates three‐dimensional connectivity but is largely confined to layers that each contain both cation enantiomers. These layers are related to one another by crystallographic symmetry and are therefore identical in composition and connectivity.